Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
American Journal of Hypertension|November 20, 2025
Long-term effect of multivitamin supplementation on incident self-reported hypertension and blood pressure changes in the COSMOS trialRikuta Hamaya, Sidong Li, Jessica Lau, et al.
The Journal of Pathology|July 9, 1999
Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancerU Wagner, K Süess, T Luginbühl, et al.
Contemporary Clinical Trials|January 9, 2023
Rationale and design of an ancillary study evaluating the effects of the cocoa flavanol and/or multivitamin interventions on falls and physical performance outcomes in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS)Meryl S LeBoff, Sharon H Chou, Kristin A Ratliff, et al.
The American Journal of Clinical Nutrition|March 16, 2022
Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trialHoward D Sesso, JoAnn E Manson, Aaron K Aragaki, et al.
The American Journal of Clinical Nutrition|January 20, 2024
Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOSChirag M Vyas, JoAnn E Manson, Howard D Sesso, et al.
Translational Stroke Research|April 27, 2024
Omega-3 Fatty Acids and Risk of Ischemic Stroke in REGARDSZsuzsanna Ament, Amit Patki, Varun M Bhave, et al.
Neurology|May 16, 2025
Use of the Brain Care Score to Estimate the Risk of Incident Cerebrovascular Events in Middle-Aged WomenDevanshi Choksi, Leidys Gutiérrez-Martínez, Pamela M Rist, et al.
JAMA Ophthalmology|March 27, 2025
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical TrialWilliam G Christen, Pamela M Rist, M Vinayaga Moorthy, et al.
ACR Open Rheumatology|May 1, 2021
Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET TrialJon T Giles, Pamela M Rist, Katherine P Liao, et al.
Global Advances in Integrative Medicine and Health|July 10, 2026
Development and Validation of a Headache Health Education Program to Serve as a Control Intervention for Non-Pharmacological Studies in MigraineKristina Twaalfhoven, Ruth Q Wolever, Meredith Beaton-Starr, et al.
Pageof 17